These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12480182)

  • 21. Neurotoxic effects of MDMA ("ecstasy") administration to neonatal rats.
    Meyer JS; Grande M; Johnson K; Ali SF
    Int J Dev Neurosci; 2004; 22(5-6):261-71. PubMed ID: 15380826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of synaptotagmin I-IV messenger RNA expression and developmental regulation in the rat hypothalamus and pituitary.
    Xi D; Chin H; Gainer H
    Neuroscience; 1999 Jan; 88(2):425-35. PubMed ID: 10197764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings.
    Reneman L; Lavalaye J; Schmand B; de Wolff FA; van den Brink W; den Heeten GJ; Booij J
    Arch Gen Psychiatry; 2001 Oct; 58(10):901-6. PubMed ID: 11576026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats.
    Thompson MR; Li KM; Clemens KJ; Gurtman CG; Hunt GE; Cornish JL; McGregor IS
    Neuropsychopharmacology; 2004 Apr; 29(4):694-704. PubMed ID: 14627999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').
    Ricaurte GA; McCann UD; Szabo Z; Scheffel U
    Toxicol Lett; 2000 Mar; 112-113():143-6. PubMed ID: 10720723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S100B overexpressing mutant mice exhibit prolonged behavioural and biochemical responses towards repeated intermittent binge treatments with MDMA.
    Kindlundh-Högberg AM; Zhang X; Svenningsson P
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):201-15. PubMed ID: 18812013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density.
    McGregor IS; Clemens KJ; Van der Plasse G; Li KM; Hunt GE; Chen F; Lawrence AJ
    Neuropsychopharmacology; 2003 Aug; 28(8):1472-84. PubMed ID: 12700695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute administration of cocaine, but not amphetamine, increases the level of synaptotagmin IV mRNA in the dorsal striatum of rat.
    Denovan-Wright EM; Newton RA; Armstrong JN; Babity JM; Robertson HA
    Brain Res Mol Brain Res; 1998 Apr; 55(2):350-4. PubMed ID: 9582453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice.
    Itzhak Y; Ali SF; Achat CN; Anderson KL
    Psychopharmacology (Berl); 2003 Mar; 166(3):241-8. PubMed ID: 12590354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan.
    Wang X; Baumann MH; Dersch CM; Rothman RB
    Neuroscience; 2007 Aug; 148(1):212-20. PubMed ID: 17629409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2-Deoxy-D-glucose prevents and nicotinamide potentiates 3, 4-methylenedioxymethamphetamine-induced serotonin neurotoxicity.
    Hervías I; Lasheras B; Aguirre N
    J Neurochem; 2000 Sep; 75(3):982-90. PubMed ID: 10936179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of dopaminergic systems in the perinatal sensitivity to 3, 4-methylenedioxymethamphetamine-induced neurotoxicity in rats.
    Aguirre N; Barrionuevo M; Lasheras B; Del Río J
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1159-65. PubMed ID: 9732373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
    Biezonski DK; Meyer JS
    J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developmental regulation of synaptotagmin I, II, III, and IV mRNAs in the rat CNS.
    Berton F; Iborra C; Boudier JA; Seagar MJ; Marquèze B
    J Neurosci; 1997 Feb; 17(4):1206-16. PubMed ID: 9006966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum.
    Kanthasamy A; Sprague JE; Shotwell JR; Nichols DE
    Neuroscience; 2002; 114(4):917-24. PubMed ID: 12379247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies.
    Vegting Y; Reneman L; Booij J
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3473-501. PubMed ID: 27568200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users.
    Semple DM; Ebmeier KP; Glabus MF; O'Carroll RE; Johnstone EC
    Br J Psychiatry; 1999 Jul; 175():63-9. PubMed ID: 10621770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium-dependent dissociation of synaptotagmin from synaptic SNARE complexes.
    Leveque C; Boudier JA; Takahashi M; Seagar M
    J Neurochem; 2000 Jan; 74(1):367-74. PubMed ID: 10617141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice.
    Bengel D; Murphy DL; Andrews AM; Wichems CH; Feltner D; Heils A; Mössner R; Westphal H; Lesch KP
    Mol Pharmacol; 1998 Apr; 53(4):649-55. PubMed ID: 9547354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.